{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T13:41:59Z","timestamp":1786714919007,"version":"build-2736575974"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Asian J Transfus Sci"],"published-print":{"date-parts":[[2016]]},"DOI":"10.4103\/0973-6247.187934","type":"journal-article","created":{"date-parts":[[2016,8,8]],"date-time":"2016-08-08T02:40:08Z","timestamp":1470624008000},"page":"145","source":"Crossref","is-referenced-by-count":3,"title":["A retrospective review of cryoprecipitate transfusion practice in Kuala Lumpur Hospital"],"prefix":"10.4103","volume":"10","author":[{"given":"JunJie","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"IntanIliana","family":"Iliassa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan Mohd ZahiruddinWan","family":"Mohammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmin","family":"Ayob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0973-6247.187934-1","unstructured":"Roback JD, Banks AAoB. Technical Manual. Bethesda MD: AABB; 2008."},{"key":"key-10.4103\/0973-6247.187934-2","first-page":"1014","volume-title":"Cryoprecipitate prepared from plasma frozen within 24 hours after phlebotomy contains acceptable levels of fibrinogen and VIIIC","author":"Yazer","year":"2010","journal-title":"Transfusion"},{"key":"key-10.4103\/0973-6247.187934-3","first-page":"146","volume-title":"Experiences in the preparation of AHG Concentrates from human plasma","author":"Pool","year":"1964","journal-title":"Bibl Haematol"},{"key":"key-10.4103\/0973-6247.187934-4","first-page":"70","volume-title":"Preparation and testing of antihemophilic globulin (Factor 8) sources for transfusion therapy in hemophilia.Description of a new sterile concentrate process for blood banks","author":"Pool","year":"1965","journal-title":"Scand J Clin Lab Invest"},{"key":"key-10.4103\/0973-6247.187934-5","first-page":"731","volume-title":"Pool's cryoprecipitate and exhausted plasma in the treatment of von Willebrand's disease and factor-XI deficiency","author":"Bennett","year":"1966","journal-title":"Lancet"},{"key":"key-10.4103\/0973-6247.187934-6","first-page":"11","volume-title":"Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant","author":"O'Shaughnessy","year":"2004","journal-title":"Br J Haematol"},{"key":"key-10.4103\/0973-6247.187934-7","first-page":"177","volume-title":"Cryoprecipitate: The current state of knowledge","author":"Callum","year":"2009","journal-title":"Transfus Med Rev"},{"key":"key-10.4103\/0973-6247.187934-8","first-page":"696","volume-title":"Thrombin generation and clot formation in methylene blue-treated plasma and cryoprecipitate","author":"Cardigan","year":"2009","journal-title":"Transfusion"},{"key":"key-10.4103\/0973-6247.187934-9","first-page":"1548","volume-title":"Transfusing methylene blue-photoinactivated plasma instead of FFP is associated with an increased demand for plasma and cryoprecipitate","author":"Atance","year":"2001","journal-title":"Transfusion"},{"key":"key-10.4103\/0973-6247.187934-10","first-page":"777","volume-title":"Practice parameter for the use of fresh-frozen plasma, cryoprecipitate, and platelets.Fresh-Frozen Plasma, Cryoprecipitate, and Platelets Administration Practice Guidelines Development Task Force of the College of American Pathologists","author":"Lundberg","year":"1994","journal-title":"JAMA"},{"key":"key-10.4103\/0973-6247.187934-11","unstructured":"Corkery C, Wright A, Charlewood R. Cryoprecipitate audit within six centres in New Zealand, New Zealand Blood Service, New Zealand. 2005."},{"key":"key-10.4103\/0973-6247.187934-12","first-page":"2122","volume-title":"Cryoprecipitate use in 25 Canadian hospitals: Commonly used outside of the published guidelines","author":"Alport","year":"2008","journal-title":"Transfusion"},{"key":"key-10.4103\/0973-6247.187934-13","first-page":"23","volume-title":"Fibrinogen replacement therapy: A critical review of the literature","author":"Franchini","year":"2012","journal-title":"Blood Transfus"},{"key":"key-10.4103\/0973-6247.187934-14","unstructured":"Department of Statistics Malaysia. Available from: https:\/\/www.statistics.gov.my\/index.php?r=column\/cone&menu_id=bjRlZXVGdnBueDJKY1BPWEFPRlhIdz09.Z."},{"key":"key-10.4103\/0973-6247.187934-15","first-page":"117","volume-title":"Appropriateness of platelet, fresh frozen plasma and cryoprecipitate transfusion in New South Wales public hospitals","author":"Schofield","year":"2003","journal-title":"Med J Aust"},{"key":"key-10.4103\/0973-6247.187934-16","first-page":"874","volume-title":"Cryoprecipitate.Patterns of use","author":"Pantanowitz","year":"2003","journal-title":"Am J Clin Pathol"},{"key":"key-10.4103\/0973-6247.187934-17","first-page":"896","volume-title":"When do we transfuse cryoprecipitate?","author":"Anderson","year":"2013","journal-title":"Intern Med J"},{"key":"key-10.4103\/0973-6247.187934-18","first-page":"35","volume-title":"Guideline on the management of bleeding in patients on antithrombotic agents","author":"Makris","year":"2013","journal-title":"Br J Haematol"},{"key":"key-10.4103\/0973-6247.187934-19","first-page":"984","volume-title":"Association between fibrinogen level and severity of postpartum haemorrhage: Secondary analysis of a prospective trial","author":"Cortet","year":"2012","journal-title":"Br J Anaesth"},{"key":"key-10.4103\/0973-6247.187934-20","unstructured":"Ayob Y. Guideline for the Rational Use of Blood and Blood Products. 2nd ed. Kuala Lumpur: National Blood Centre, Ministry of Health Malaysia; 2008."},{"key":"key-10.4103\/0973-6247.187934-21","first-page":"24","volume-title":"Guidelines for the diagnosis and management of disseminated intravascular coagulation.British Committee for Standards in Haematology","author":"Levi","year":"2009","journal-title":"Br J Haematol"},{"key":"key-10.4103\/0973-6247.187934-22","first-page":"R17","volume-title":"Management of bleeding following major trauma: A European guideline","author":"Spahn","year":"2007","journal-title":"Crit Care"},{"key":"key-10.4103\/0973-6247.187934-23","first-page":"441","volume-title":"Guidelines for cryoprecipitate transfusion","author":"Droubatchevskaia","year":"2007","journal-title":"Br Columbia Med J"},{"key":"key-10.4103\/0973-6247.187934-24","first-page":"R52","volume-title":"Management of bleeding following major trauma: An updated European guideline","author":"Rossaint","year":"2010","journal-title":"Crit Care"},{"key":"key-10.4103\/0973-6247.187934-25","first-page":"266","volume-title":"The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage","author":"Charbit","year":"2007","journal-title":"J Thromb Haemost"}],"container-title":["Asian Journal of Transfusion Science"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T13:23:01Z","timestamp":1786713781000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0973-6247.187934"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016]]}},"alternative-id":["187934"],"URL":"https:\/\/doi.org\/10.4103\/0973-6247.187934","relation":{},"ISSN":["0973-6247"],"issn-type":[{"value":"0973-6247","type":"print"}],"subject":[],"published":{"date-parts":[[2016]]}}}